Mrinal Shah
Director, Clinical Scientist, Intellia Therapeutics, Inc.
Graduation Year: 2010
Thesis: DNMT3B7, A Truncated DNMT3B Protein Found in Cancer Cells, Disrupts Murine Embryonic Development and Alters DNA Methylation In Myc-Induced Lymphomas
Advisor: Lucy Godley